How to Avert Disaster: (CMCCP) Chemistry, Manufacturing & Controls (CMC) Certified Professional™ Chemistry Certification

December 24, 2018
Coronavirus 2020: Everything Pharmaceutical Personnel Should Know

Just this week, biotech company DBV Technologies learned a harsh lesson in proper CMC protocol, as they were forced to withdraw their approval application of Viaskin Peanut, a peanut allergy treatment targeting children 4-11 years old. The FDA cited chemistry, manufacturing and controls issues as their reason for their rejection of DBV’s biologics license application, causing the company’s stock to drop a staggering 67.4%.


Even more disheartening, it appears that both the FDA and DBV believe the treatment is viable and effective. This potentially life-saving medication is now years behind its scheduled time-to-market because the proper CMC certification protocols were not in place, an avoidable error.


This lesson reminds those of us in the pharmaceutical and biotech space of the great importance of CMC certification for professionals developing and manufacturing drugs and biologics. At CfPIE, our Chemistry, Manufacturing & Controls (CMC) Certified Professional™ Chemistry Certification program is rigorous and taught by instructors with real-world knowledge of how to avoid CMC pitfalls and deliver high-quality results, on-time, with FDA-approval.


Better still, our CMC certification program is flexible, adapting both to your specific learning needs and your schedule. Students can choose from 14 course options to complete their 4-course requirement, and final exams are completed online to suit your schedule. 


To learn more about our CMC certification program, visit the program overview page, or browse our programs page for a full listing of certification courses we offer.
 

Source:

https://www.investors.com/news/technology/dbv-stock-peanut-allergy-treatment/





paper_plane

Need more information on our life-science training course?

Get In Touch With Us Today!

Contact Us

Blog Categories

Operational Excellence and Sustained Procedural Discipline
November 5, 2026
Pharmaceutical workforce readiness and operational excellence are vital for product quality and safety. Learn more about preventing FDA Warning Letters.
Gap 4: What FDA Warning Letters Reveal About Data Integrity and Scientific Documentation
November 4, 2026
FDA Warning Letters show how incomplete or unreliable data can undermine investigations, batch decisions, oversight, and the pharmaceutical quality system.